1218 results found
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
To support the development of the highest quality guidelines and advice, NHMRC has robust processes in place to manage conflict of interest and to use recognised tools to assess the evidence for quality and bias.
When it comes to health and medical research in Australia, our scientists are pioneering key advances to better understand health conditions and answer fundamental questions. This evening, we had the pleasure of launching the highly anticipated 16th edition of our flagship publication, 10 of the Best.
NHMRC is the Australian Government’s primary health and medical research funding agency. With NHMRC support, Australia undertakes outstanding health and medical research which has contributed to significant improvements in individual and population health.
The National Health and Medical Research Council (NHMRC) has honoured the outstanding achievements with its annual Research Excellence Awards announced this evening in Canberra.
An estimated 1 in 10 Australian adults (10%) - about 1.7 million people in 2011 - 12 - had biomedical signs of chronic kidney disease1
Associate Professor Joshua Vogel is a Principal Research Fellow at the Burnet Institute in Melbourne, where he co-heads the Global Women’s and Newborn’s Health Group. His research focuses on addressing maternal and perinatal health issues affecting women and families in limited-resource settings. Associate Professor Vogel was the winner of the 2020 Peter Doherty Investigator Grant Award, and the Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.
Information for grant holders submitting progress, final and additional reports on grant outcomes.
NHMRC opened a Targeted Call for Research (TCR) into Social and Emotional Wellbeing (SEWB) for Indigenous Peoples from Early Life to Young Adults on 15 November 2017 which closed on 7 February 2018.
An evaluation of NHMRC-funded dementia and diabetes research delves into the outputs, outcomes and pathways to impact arising from NHMRC-supported research in the areas of dementia and diabetes by analysing data captured by Scopus-indexed publications. It employs AI-driven analytics and narrative techniques combined with novel bibliometric methods to identify impacts or pathways to impact. The report also benchmarks NHMRC's contributions against major international funders, offering insights from 2000 to 2023.
Honouring exceptional commitment and long-term contributions to NHMRC's mission and priorities.